ArticleTranslational lung cancer research2025

Pathological complete response and long-term survival by pembrolizumab based immunochemotherapy in epidermal growth factor receptor mutated non-small cell lung cancer post-tyrosine kinase inhibitor failure: a case report and tumor microenvironment analysis.

Sangtian Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.